Introduction
Soluble mitogens and antimitogens have long been viewed as important regulators of cell proliferation, but it is now accepted that insoluble factors, especially components of the extracellular matrix (ECM), have equally essential roles in the proliferation of most nontransformed cell types. Soluble mitogens and ECM proteins jointly regulate activation of the G1 phase cyclin-dependent kinases (cdks) cdk4/6 and cdk2, which are required for S phase entry [1] . ECM proteins signal by binding and activating the integrin family of cell surface receptors, and many studies have identified integrin-dependent signaling events that support G1 phase progression, especially the induction of cyclin D1 mRNA and protein and the downregulation of the cip/kip family of cdk inhibitors [1] . These effects control activation of cdk4/6 and cdk2, respectively, which in turn catalyze the inactivating phosphorylations of the retinoblastoma protein (Rb) and the related proteins p107 and p130. Rb phosphorylation results in the release of sequestered E2Fs and the induction of E2F-dependent genes required for S phase.
Integrin-dependent signaling events implicated upstream of cyclin D1 and the cip/kips include the activation of ERK MAP kinases, Rho family GTPases, and FAK [1] . However, little is known about whether and how these pathways are activated in physiologically relevant mechanical microenvironments. This gap in knowledge arises at least in part because integrin-regulated events have typically been identified in cultured cells after complete blockade of ECM-integrin binding (e.g., by incubating cells in suspension or on polylysine-coated dishes) or by preventing integrin clustering (e.g., by disrupting the actin cytoskeleton with depolymerizing drugs or inhibitors of Rho GTPase activation or signaling). These approaches result in much more severe changes in integrin occupancy, F-actin polymerization, and Rho GTPase activity than are likely to occur physiologically. Additionally, a pervasive shortcoming of traditional cell biological approaches to the study of ECM function is that cells are typically cultured on nondeformable substrata (culture dishes or glass coverslips), which have little relationship to the elastic (also called ''compliant'') ECM that cells encounter in vivo. Because a hallmark of ECM-cell interactions is the ability to sense extracellular stiffness, tissue compliance may be an important determinant of downstream adhesion-dependent signaling events.
Some studies have used collagen gels to study the effect of a more compliant matrix on integrin signaling and the cell cycle. These studies showed that human foreskin fibroblasts in free-floating collagen gels have high levels of p27, do not phosphorylate ERK, and do not express cyclin D1 [2, 3] . Others have reported that increased p21 cip1 or p15 INK4B is responsible for G1 phase arrest that occurs when cells are plated on soft collagen gels [4, 5] . FAK autophosphorylation, ERK activity, and Rho activation are also impaired when cells are cultured on or in soft collagen matrices or Matrigels [2, 6] . Although these results suggest that changes in matrix stiffness recapitulate the effects seen upon complete adhesion blockade, collagen gels are much softer than many physiological tissues (elastic moduli of 10-50 pascals [Pa] versus 100-100,000 Pa) [7, 8] . Moreover, changing the stiffness of collagen gels by altering collagen concentration inherently affects the integrin ligand concentration, so observed effects cannot be strictly attributed to changes in matrix elasticity. The same complication exists when cells are cultured in Matrigel, which is also less well defined chemically.
Careful control of substratum elasticity is perhaps best achieved by seeding cells on ECM-coated biocompatible hydrogels because elasticity can be varied independently of matrix concentration [9, 10] . Hydrogels based on polyacrylamide have elastic moduli of w1,500-150,000 Pa, a range which encompasses the stiffness of most physiological tissues [10] . Cells plated on soft hydrogels show a decrease in cell number [9, 11] , but the molecular events that underlie cellcycle control by matrix stiffness remain undefined. In this report, we combine biophysical measurements of tissue elasticity with a molecular analysis of the cell cycle on complianceappropriate hydrogels to elucidate the subcellular effects of matrix stiffness on cell proliferation.
Results

A Small Subset of Adhesion-Dependent Signaling Events Accounts for Cell-Cycle Control by Matrix Stiffness
We adapted the use of deformable matrix protein-coated acrylamide hydrogels to a molecular analysis of the cell cycle. Quiescent mouse embryonic fibroblasts (MEFs) were plated on fibronectin (FN)-coated hydrogels having elastic moduli within the physiological range [7, 12] . Serum-stimulated cellcycle entry was barely detected when MEFs were seeded on low-stiffness FN substrata (elastic modulus < 2000 Pa), and the degree of S phase entry increased with matrix stiffness until optimal cycling was obtained at w24,000 Pa ( Figure 1A) . Remarkably, the same range of matrix stiffness regulated S phase entry in MCF10A mammary epithelial cells ( Figure 1A ), vascular smooth muscle cells (VSMCs; Figure 1A ), and osteoblastic cells (see Figure S1 available online). Thus, the effect of matrix stiffness on G1 and S phase progression is widely conserved and independent of the rigidity of individual tissue microenvironments. Mitogenesis (assessed as mRNA induction of cyclin A, an E2F target required for S phase entry and progression) was dependent on matrix stiffness regardless of whether cells entered G1 phase from G0 or G2/M ( Figure 1B) , indicating that both cell-cycle reentry from quiescence and subsequent cycling are controlled by ECM stiffness. Subsequent experiments used hydrogels prepared at , cells were fixed and BrdU incorporation was determined. The graph compiles results from an individual experiment for each cell type and shows percent maximal BrdU incorporation compared to the stiffest hydrogel. The shaded area highlights the range of elastic moduli measured in mouse mammary glands and arteries as determined by milliprobe indentation and atomic force microscopy (AFM) (see Table S2 ).
(B) MEFs were synchronized at G0 (by 48 hr serum starvation) or at G2/M (by treatment with 5 mg/ml nocodazole for 24 hr). The cells were reseeded on hydrogels and stimulated with 10% fetal bovine serum (FBS). RNA was isolated 24 hr after reseeding and analyzed by qPCR for cyclin A or cyclin D1 mRNAs. Data in (B) and (C) are mean 6 standard deviation (SD) of duplicate PCR reactions. (C) Serum-starved cells were reseeded on high-stiffness (H) and low-stiffness (L) hydrogels with mitogens. Cyclin D1 mRNA was measured by qPCR at times corresponding to optimal induction (12 hr for MCF10A cells, 24 hr for VSMCs, and 9 hr for MEFs).
(D and E) Serum-starved MEFs were pretreated with dimethyl sulfoxide (vehicle) or U0126 (U0) prior to reseeding on hydrogels and stimulation with 10% FBS. Reseeded cells were collected at the indicated times and analyzed by western blotting.
w2,000 and w24,000 Pa, referred to hereafter as low and high stiffness, respectively. As in previous reports [13, 14] , cell spreading and cytoskeletal organization were inhibited when either epithelial or mesenchymal cells were plated on the low-stiffness acrylamide hydrogels ( Figure S2 ). Because decreased cell spreading has been associated with decreased integrin signaling and S phase entry [15] , we initially thought that the cell-cycle inhibition reflected an overall decrease in integrin signaling. Overall inhibition of integrin signaling prevents the mitogen-dependent induction of cyclin D1 mRNA and the mitogen-dependent downregulation of the p21 cip1 and p27 kip1 cdk inhibitors [1, 16, 17] . In contrast, the soft substratum that prevents mitogenesis inhibited the induction of cyclin D1 mRNA and protein ( Figures  1C and 1D ) but not the G1 phase downregulation of p21 cip1 or p27 kip1 ( Figure 1E ). Thus, matrix compliance targets a discrete subset of adhesion-dependent cell-cycle events. Cyclin D1 gene expression was similarly regulated by matrix stiffness in cells entering G1 phase from G0 or G2/M ( Figure 1B ).
Previous studies on glass or plastic substrata have indicated that the mid-G1 phase induction of cyclin D1 requires sustained ERK activity [18, 19] . In agreement with these results, we found that serum-stimulated MEFs plated on the high-stiffness substratum used ERK activity to induce cyclin D1 protein as determined with the MEK inhibitor U0126 ( Figure 1D ). However, a comparison of ERK activation in cells cultured on low-and high-stiffness substrata showed that the magnitude and duration of ERK phosphorylation were not strongly affected by this range of ECM stiffness ( Figure 2A ; Figure S3A ) despite large differences in expression of cyclin D1 ( Figures 1C and 1D ) and mitogenesis ( Figure 1A) . Induction of the ERK-dependent immediate-early genes Fra-1 and JunB, associated with cyclin D1 gene expression [18, 19] , was also similar on the high-and low-stiffness substrata (Figures 2B-2D; Figure S3B ), indicating that ERK translocation to the nucleus and ERK-dependent transcription were proceeding normally. Thus, despite the fact that ERK activity is adhesion dependent as determined by the complete blockade of cell adhesion or actin depolymerization [1] , changes in ERK (B-D) Serum-starved cells were reseeded on high-stiffness (H) and low-stiffness (L) hydrogels with mitogens. RNA was collected from quiescent cells (G0) and cells stimulated with 10% FBS at times optimal for JunB and Fra-1 mRNA induction (1 and 3 hr, respectively) in the three cell types. Fra-1 and JunB mRNA levels were determined by qPCR and normalized to 18S rRNA and are plotted relative to the levels of the high-stiffness samples. Data are mean 6 SD of duplicate PCR reactions.
activity are not responsible for the effect of matrix stiffness on cyclin D1 gene expression.
Regulated FAK Localization as a Mechanosensor for Cell-Cycle Progression
The overall extent of immediate-early gene induction, cyclin D1 gene induction, and mitogenesis was similar in cells plated on glass versus the high-stiffness hydrogels ( Figure S4 ), but focal adhesions were less robust than those seen on traditional glass coverslips as assessed by immunostaining for FAK, Y397-phosphorylated FAK (FAK pY397 ), vinculin, and paxillin ( Figure S5 ). By these same criteria, focal adhesions were undetected in cells plated at low matrix stiffness ( Figure S5 ). FAK phosphorylation has been linked to mechanotransduction and cyclin D1 gene expression [20] [21] [22] , and indeed we found that FAK autophosphorylation at Y397 was reduced when cells were cultured on the low-stiffness ECM ( Figure 3A) . Conversely, ectopically expressed FRNK or nonphosphorylatable FAK (FAK Y397F ) suppressed cyclin D1 mRNA expression in MEFs incubated on the high-stiffness ECM ( Figures 3B and 3C ). This effect did not reflect a global disruption of integrin complexes, because vinculin-containing focal adhesions persisted in the presence of FRNK or FAK Y397F ( Figure S6 ). Cyclin D1 induction was also impaired in FAK null cells ( Figure S7A ). Thus, FAK inhibition or depletion on stiff substrata phenocopies the effect of low matrix stiffness on cyclin D1 gene expression.
However, we saw variable degrees of inhibition of Y397 phosphorylation (w30%-80%) when serum-stimulated cells were plated on low-stiffness hydrogels despite consistent inhibitory effects on cyclin D1 mRNA. Additionally, an activated FAK allele, CD2-FAK [23] , failed to rescue cyclin D1 gene expression ( Figure 3D ) in MEFs plated on soft FN-coated hydrogels despite efficient ectopic expression (see Figure 3D legend) and localization to focal adhesions on the highstiffness substratum ( Figure S8 ). Thus, constitutive FAK activity is not sufficient to overcome the inhibitory effect of the low-stiffness matrix on S phase entry. We therefore considered the possibility that matrix compliance was regulating the association of FAK with integrins. Indeed, confocal immunofluorescence microscopy showed that endogenous FAK and activated integrins (assessed by talin staining; [24] ) efficiently colocalized in MEFs cultured on the high-stiffness ECM but not in MEFs cultured on the low-stiffness ECM ( Figure 3E ; Figures S9A and S9B) . These results extend work of others showing that matrix stiffness controls formation of b1-integrin/FAK/talin complexes as determined by coimmunoprecipitation in ectopic expression paradigms [20] . They also distinguish the integrin complexes that form in response to low matrix stiffness from standard focal complexes, focal adhesions, and 3D adhesions (which are reported to have constitutive recruitment of FAK to integrins) and reveal a potential similarity to fibrillar adhesions [25] . A compliancedependent regulation of FAK localization can explain why expression of CD2-FAK does not rescue cyclin D1 gene induction on a low-stiffness substratum whereas mislocalization of endogenous FAK with FRNK or FAK Y397F inhibits cyclin D1 gene expression on a stiff substratum. Collectively, these results indicate that cells respond to changes in extracellular stiffness by regulating the degree to which FAK is stably associated with activated integrins. In this model, compliancedependent changes in FAK autophosphorylation are a secondary consequence of altered FAK-integrin association.
Mechanical Signaling to the Cell Cycle Transduced by the FAK-Rac-Cyclin D1 Pathway Studies on glass or plastic substrata have indicated that FAK can regulate at least four effectors of cyclin D1 gene expression: ERK activity [26] , Rho activity [27] , expression of the transcription factor KLF8 [22] , and Rac activity [28, 29] . We investigated which, if any, of these effector pathways was responsible for the induction of cyclin D1 by matrix stiffness. We could discount ERK as the critical FAK effector because ERK activity was not strongly inhibited by functionally relevant changes in matrix stiffness (Figure 2 ) or FRNK ( Figure S7B ). Rho activity is inhibited by the low-stiffness substrata ( [6] ; Figure S10A ), but we reasoned that Rho is not the major FAK effector, at least in terms of ECM compliance, because Rho has been linked to cyclin D1 gene expression through ERK and because expression of activated Rho did not rescue cell spreading ( Figure S10B ) or cyclin D1 gene expression in serum-stimulated MEFs cultured on a soft substratum in either the absence or presence of activated FAK ( Figure S10C ). Expression of KLF8 mRNA was barely detectable by quantitative real-time reverse transcriptasepolymerase chain reaction (qPCR) in MEFs (w100-fold lower levels than transcripts for Fra-1 or JunB; Table S1 ), as expected from work by others demonstrating that FAK overexpression is required for KLF8 induction [22] .
We recently reported that the mid-G1 phase induction of cyclin D1 mRNA requires Rac activity [30] , and indeed we found that Rac inhibition blocked mitogen-stimulated cyclin D1 mRNA induction when cells were plated on the high-stiffness substratum ( Figure 4A ). Moreover, Rac GTP loading in MEFs ( Figures 4B and 4C ) and VSMCs ( Figure S11 ) was strongly inhibited by the low-stiffness substratum, whereas expression of an activated Rac (Rac V12 ) rescued cyclin D1 gene expression on the soft substratum ( Figure 4D ). The effect of matrix stiffness on Rac-dependent cyclin D1 gene expression requires FAK, because FRNK or FAK Y397F expression blocked Rac activity on the high-stiffness matrix ( Figures 4B and 4C) . Collectively, these data causally link FAK-dependent Rac activation to the effect of ECM compliance on cyclin D1 expression. However, activated Rac did not rescue S phase entry in MEFs on the soft substratum ( Figure 4E ), indicating that there must be an additional effect of matrix elasticity on mitogenesis.
Matrix Stiffness Regulates Cyclin D1-Dependent Rb Phosphorylation
The mid/late-G1 phase phosphorylation of Rb results in the release of associated E2Fs and transcription of E2F-dependent genes required for S phase entry. Rb phosphorylation, as determined by gel shift, and induction of cyclin A were inhibited by low matrix stiffness in MEFs ( Figure 5A ). Ectopically expressed cyclin D1 rescued Rb phosphorylation, but efficient rescue required high levels of overexpression ( Figure 5B ; >100 moi). More moderate overexpression (30 moi) rescued Rb phosphorylation poorly despite readily detected cdk4 ( Figure 5B) . Similarly, cyclin D1 overexpression rescued S phase entry (determined as Ki-67-expressing nuclei) poorly in serum-stimulated MEFs on the low-stiffness ECM, even though inactivation of Rb with HPV-E7 rescued mitogenesis efficiently ( Figure 5C ). Similar results were observed with MCF10A cells ( Figure S12 ). Inefficient Rb phosphorylation could result from upregulated expression of inhibitory proteins for cdk4/6 (the INK4s) or cdk2 (the cip/kips) because these cdks jointly inactivate Rb. However, none of the INK4s (p15, p16, p18, and p19; Figure 5D ) or the widely expressed cip/ kips (p21 and p27; see Figure 1E ) were regulated by the range of matrix stiffness that controls mitogenesis. Collectively, these data indicate that ECM compliance regulates cyclin D1-dependent Rb phosphorylation most likely through an effect on cdk4/6 binding and/or activity. The integrin signaling mechanism underlying the effect of matrix stiffness on cyclin D1-dependent Rb phosphorylation requires FAK, because ectopically expressed FRNK inhibited S phase entry in serum-stimulated cyclin D1-overexpressing MEFs cultured on high-stiffness hydrogels ( Figure 5E ). Conversely, CD2-FAK synergized with ectopically expressed cyclin D1 to promote S phase entry in cells on the low-stiffness substratum ( Figure 5F ), reaching about half of the level of bromodeoxyuridine (BrdU) incorporation seen on the high-stiffness ECM.
Tissue Stiffening at Sites of Cell Proliferation In Vivo
To test the link between tissue stiffness and cell proliferation in vivo, we first isolated mammary glands, thoracic aortae, and femoral arteries from mice and compared their elasticities to the range of matrix stiffness that regulates mitogenesis as determined by the hydrogel analyses. Milliprobe indentation or atomic force microscopy (AFM) indicated that these tissues have an elastic modulus range of 600-4300 Pa (Table S2 ). This stiffness range strongly inhibits mitogenesis (see Figure 1A) , indicating that physiological compliance of the mammary gland and major arteries acts as a cell-cycle inhibitor. We then used fine-wire femoral artery injury in mice to examine potential changes in tissue stiffness occurring at sites of cell proliferation in vivo. The injury procedure disrupts the integrity of the intimal endothelium, allowing for platelet aggregation and the dedifferentiation of medial VSMCs to a proliferative state. Although an intact endothelium is eventually restored, the transient denudation results in the formation of a ''neointima'' containing proliferating VSMCs. Immunohistochemistry confirmed VSMC proliferation, as assessed by BrdU incorporation, in the neointima of injured arteries (Figure 6A) . These regions of cell proliferation could be localized by monitoring a-smooth muscle actin (SMA) expression, which is lost in both the neointima and underlying media as VSMCs dedifferentiate to the proliferative state ( Figure 6A , box 3 in right panel). Note, however, that the SMA staining pattern of the artery was mosaic and that positive staining regions were also detected. These SMA-positive regions likely reflect uninjured areas of the artery (see box 1) and sites of injury where VSMCs have dedifferentiated, proliferated, and then redifferentiated (boxes 2 and 4).
We rendered the vascular injury model compatible with the analysis of stiffness in fresh tissue by performing femoral artery injuries on transgenic mice in which the SMA promoter drives GFP. Vascular injury in this line resulted in discrete GFP-positive and -negative regions ( Figure 6B ), whereas GFP fluorescence in uninjured control arteries was nearly uniform ( Figure 6B ). We used AFM in force mode to probe the compliance of the GFP-negative regions (neointimas) and compared the results to those obtained for the uninjured contralateral arteries of the same SMA-GFP mice. We excluded GFP-positive regions of injured arteries from the analysis in order to eliminate the confounding effects of VSMC redifferentiation (see above). The results revealed regions of clear arterial stiffening 2 weeks after injury (the time at which BrdU incorporation is detected in vivo), with an increase in both the mean stiffness and variance at sites of VSMC proliferation ( Figure 6C) . Remarkably, the degree of stiffening seen at sites of injury and VSMC proliferation in mice reached the range of elastic moduli that supported mitogenesis in the hydrogel studies ( Figure 1A ).
Discussion
Matrix Stiffness and the Cell Cycle Our study describes cellular and molecular effects of matrix compliance on the cell cycle. The elastic moduli that regulate mitogenesis in MEFs, mammary epithelial cells, VSMCs, and osteoblastic cells are strikingly similar, indicating that the effect of tissue compliance on the cell cycle is widely conserved and independent of a cell's particular microenvironment. The mitogen-dependent induction of cyclin D1 mRNA is strongly affected by the range of matrix elasticity that controls mitogenesis, whereas other mitogenic events previously identified as being integrin dependent (the expression of cdk-inhibitory proteins and immediate-early genes, as well as the activation of ERK) are relatively resistant. Thus, adhesion-mediated cell-cycle events in G1 phase are not binary but have distinct compliance thresholds, with many of the previously identified events proceeding normally in the range of matrix stiffness that strongly inhibits mitogenesis.
In addition to regulating the expression of cyclin D1, matrix stiffness controls the ability of ectopically expressed cyclin D1 to stimulate Rb phosphorylation and S phase entry. This effect is of particular interest in mammary cells given the frequent overexpression of cyclin D1 in breast cancer [31, 32] . A common idea is that overexpressed cyclin D1 acts cooperatively with other oncogenic events, and our results indicate that tissue stiffening, a hallmark of mammary tumors, can be considered as one of these complementing oncogenic events because it is required for the efficient function of overexpressed cyclin D1. Additionally, our data indicate that oncogenic events inactivating Rb, such as expression of HPV-E7, can override the inhibitory effect of physiological ECM compliance on the cell cycle without increasing ECM stiffness because they deregulate the molecular events targeted by tissue compliance.
FAK Localization as a Mechanosensor for the Cell Cycle
Paszek et al. [6] reported that FAK phosphorylation at Y397, but not its localization to integrins, is regulated by matrix stiffness in mammary epithelial cells and fibroblasts. Although we also observed changes in FAK autophosphorylation in response to changing extracellular stiffness and intracellular tension, our data and those of Wei et al. [20] support a model in which FAK localization, rather than its autophosphorylation at Y397, represents the primary compliance effect. Wozniak et al. [33] also described a compliance-dependent localization of FAK in mammary cells undergoing tubulogenesis.
Although CD2-FAK is unable to rescue cyclin D1 expression in cells plated on a low-stiffness substrate, CD2-FAK is able to synergize with ectopically expressed cyclin D1 to rescue a large part of S phase entry. These results suggest that the inhibitory effects of low matrix stiffness on cyclin D1 mRNA and cyclin D1-dependent mitogenesis are mechanistically distinct downstream of FAK. We envision that differential localization of the relevant FAK substrates will ultimately account for these differential effects of CD2-FAK on compliance-dependent cell cycling. The focal adhesion proteins paxillin and p130
Cas have the potential to regulate the FAKdependent activation of Rac through CrkII-DOCK180/Elmo or Pkl-Pix-Pak, and both proteins have been implicated in mechanosensing [34, 35] . It will be interesting to determine whether FAK and these focal adhesion components have common or distinct compliance thresholds for localization to activated integrins. Because activated Rac does not rescue S phase entry in cells plated on the low-stiffness substratum, the FAK effector pathway (or pathways) regulating cyclin D1-dependent Rb phosphorylation extends beyond Rac.
Tissue Stiffness and Cell Cycling In Vivo Direct measurement of arterial elasticity at sites of proliferation in mice demonstrates that tissue stiffness increases at sites of VSMC proliferation in vivo and that regions of the remodeled matrix attain elastic moduli compatible with cell cycling. Although the relationship between arterial compliance and VSMC proliferation in vivo is complicated by pulsatile blood flow, the plasticity of VSMC differentiation, and the effects of antiproliferative signals derived from adjacent intimal endothelial cells [36] , our studies indicate that injury-associated change in the elasticity of the VSMC microenvironment is a critical regulator of proliferation in cardiovascular disease. Although we studied tissue stiffness at sites of vascular injury, a comparable elastic modulus has been reported for atherosclerotic lesions [37] . Similarly, the reported elastic moduli of mammary tumors [38] should be sufficient to support cyclin D1 gene induction and mitogenesis according to our hydrogel analysis. Thus, control of the cell cycle by tissue compliance may contribute widely to the absence of cell proliferation in normal tissues as well as to the increased proliferation of cells seen during pathological ECM remodeling and stiffening of the microenvironment.
Experimental Procedures
Serum-starved cells were trypsinized and replated on matrix protein-coated acrylamide hydrogels [39] and stimulated with mitogens. Cells were lysed and analyzed for expression of mRNA and protein by qPCR and western blotting, respectively. Rac and Rho GTPase activity were determined by G-LISA (Cytoskeleton). Epifluorescence microscopy was used to measure BrdU incorporation and Ki-67 and to visualize F-actin [39] . Focal adhesion formation was determined by confocal immunofluorescence microscopy, and FAK-talin colocalization was quantified by morphometric analysis of confocal images. The elastic moduli of mouse mammary glands, aortae, and femoral arteries were determined with a custom-made microindenter or by AFM in force mode. Some experiments used cells infected with adenoviruses encoding LacZ, GFP, cyclin D1, HPV-E7, or dominant-negative or activated alleles of FAK and Rac. See Supplemental Experimental Procedures for detailed materials and methods.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, three tables, and twelve figures and can be found with this article online at http:// www.cell.com/current-biology/supplemental/S0960-9822(09)01548-6. Six-month-old male C57BL/6 mice were subjected to fine-wire femoral artery injury and administered BrdU. (A) The external and internal elastic laminae (EEL and IEL, respectively) were visualized by elastin staining, and overall arterial morphology was determined by staining with hematoxylin and eosin. These procedures allowed for the identification of the adventitia (AD), the medial layer of VSMCs (M), and the site of injury (NI, neointima). Adjacent sections were analyzed by immunohistochemistry with anti-BrdU (1299964, Roche) to visualize proliferating cells (left panel) and anti-a-smooth muscle actin (clone 1A4, Sigma) to visualize regions of differentiated and dedifferentiated VSMCs (right panel). Clockwise and counterclockwise arrows in the right panel indicate the IEL and EEL, respectively. Boxed regions highlight distinct patterns of VSMC differentiation in the media and neointima. (B) Six-month-old male SMA-GFP mice were subjected to fine-wire femoral artery injury. Uninjured and contralateral injured arteries were isolated, carefully opened, and imaged for GFP fluorescence. Representative areas of uninjured and injured arteries are shown for a single mouse. (C) Uninjured (control) and injured femoral arteries from SMA-GFP mice were collected 2 weeks after the fine-wire injury procedure. AFM was used to measure the elastic modulus of several GFP-positive regions of uninjured arteries and GFP-negative regions of injured arteries. The figure compiles AFM measurements obtained from four mice (p = 0.0029 by one-way t test with Welch correction for unequal variance; p for unequal variance < 0.0001).
